Neuralink’s inventor, Elon Musk, disclosed that the first patient to get the company’s brain chip has not only fully recovered but is also capable of using their thoughts to operate a computer mouse.
During a Spaces event, Musk announced this wonderful news on the social media site X. “Progress is good, and the patient seems to have made a full recovery, with no ill effects that we are aware of,” he wrote, expressing happiness with the progress. The patient only needs to think to move a mouse around the screen.”
Neuralink implanted the chip in its first human patient last month after being granted approval in September to recruit participants for human trials. The procedure entails a robot implanting a brain-computer interface device surgically in a part of the brain that controls movement intention.
Originally intended to let users to manipulate a computer’s mouse or keyboard with their thoughts, Musk sees wider uses for the technology, hoping to treat diseases including obesity, autism, melancholy, and schizophrenia.
Although Neuralink’s encouraging advancements represent a major stride forward, the company has come under fire for safety procedures; it was recently penalized for breaking US Department of Transportation regulations pertaining to the transportation of hazardous chemicals.
Despite difficulties, Neuralink’s technology has the potential to revolutionize medical procedures in the future, as demonstrated by its success in enabling thought-controlled mouse movements.
I am a dedicated student currently in my seventh semester, pursuing a degree in International Relations. Alongside my academic pursuits, I am actively engaged in the professional field as a content writer at the Rangeinn website.